(Circulation. 2005;112:1.)
© 2005 American Heart Association, Inc.
Issue Highlights
 |
PERIODONTAL DISEASE AND CORONARY HEART DISEASE: A REAPPRAISAL OF THE EXPOSURE, by Beck et al.
|
|---|
There currently is great interest in understanding the role
of certain chronic infections as risk factors for cardiovascular
disease. In this regard, prior studies have suggested that chronic
periodontal disease is associated with increased cardiovascular
risk, although it remains possible that the confounding effects
of smoking and other classical risk factors explain the association.
In this issue of
Circulation, Beck and colleagues investigated
the relation between periodontal disease and prevalent coronary
heart disease in 5002 participants in the fourth examination
of the Atherosclerosis Risk in Communities Study. They observed
that elevated serum IgG antibodies to several oral pathogens
were associated with coronary heart disease, but findings on
oral examination were not. Although further prospective studies
of this question are needed, the present study suggests that
the host response to oral infection may be more important for
cardiovascular risk than the local extent of periodontal disease.
See p
19.
 |
EFFECTS OF CANDESARTAN ON THE DEVELOPMENT OF A NEW DIAGNOSIS OF DIABETES MELLITUS IN PATIENTS WITH HEART FAILURE, by Yusuf et al.
|
|---|
Angiotensin-converting enzyme inhibitors and angiotensin receptor
blockers (ARBs) have been associated with a lower incidence
of diabetes mellitus in clinical trials of hypertensives and
other high-risk patients. However, it is less clear if use of
renin-angiotensin axis inhibitors lowers the risk of diabetes
in patients with heart failure. In this issue of
Circulation,
Yusuf and colleagues analyze data from the CHARM trial to assess
the risk of developing new-onset diabetes (a prespecified secondary
outcome) in more than 5000 heart failure patients randomized
to candesartan (an ARB) or placebo. The investigators report
that candesartan use was associated with a 22% reduction in
incidence of diabetes compared with placebo. The reduction in
incidence of diabetes was consistent across clinical subgroups
(age, sex, body mass index) and was particularly striking in
patients with a relatively preserved ejection fraction. The
authors emphasize that use of ARBs in heart failure patients
provides added value by lowering the future risk of diabetes.
See p
48.
 |
STATIN TREATMENT AFTER ONSET OF SEPSIS IN A MURINE MODEL IMPROVES SURVIVAL, by Merx et al.
|
|---|
The clinical benefits achieved with HMG-CoA reductase inhibitors
have been shown to extend well beyond the recognized lipid-lowering
effects of these agents. The pleiotropic effects attributed
to statins include increased bioavailable nitric oxide, increased
antioxidant properties, inhibition of inflammatory responses,
and improvement of endothelial dysfunction. Interestingly, investigators
have recognized that these pleiotropic effects may be exploited
to offer a therapeutic advantage in clinical situations other
than atherothrombotic vascular disease. For example, Merx et
al have previously shown that the antiinflammatory effects of
statins mediate responses to sepsis; pretreatment with statins
improved survival in a murine model of sepsis. In this issue
of
Circulation, Merx et al extend their previous work and examine
the effects of initiating statin therapy after sepsis has been
established. These studies may have implications for how clinicians
treat sepsis in the future. See p
117.
Visit http://www.circ.ahajournals.org:
 |
Images in Cardiovascular Medicine
|
|---|
Detection of Luminal-Intimal Border and Coronary Wall Enhancement
in Intravascular Ultrasound Imaging After Injection of Microbubbles
and Simultaneous Sonication With Transthoracic Echocardiography.
See p
e1.
Detection of Carotid Atherosclerotic Plaque Ulceration, Calcification, and Thrombosis by Multicontrast Weighted Magnetic Resonance Imaging. See p e3.
Primary Lymphoma of the Heart. See p e5.
 |
Book Review
|
|---|
Computed Tomography of the Coronary Arteries. See p
e7.
 |
Correspondence
|
|---|
See p
e9.
Related Articles:
-
Statin Treatment After Onset of Sepsis in a Murine Model Improves Survival
- Marc W. Merx, Elisa A. Liehn, Jürgen Graf, Annette van de Sandt, Maren Schaltenbrand, Jürgen Schrader, Peter Hanrath, and Christian Weber
Circulation 2005 112: 117-124.
[Abstract]
[Full Text]
-
Detection of Luminal-Intimal Border and Coronary Wall Enhancement in Intravascular Ultrasound Imaging After Injection of Microbubbles and Simultaneous Sonication With Transthoracic Echocardiography
- Manolis Vavuranakis, Ioannis A. Kakadiaris, Sean M. OMalley, Christodoulos Stefanadis, Sophia Vaina, Maria Drakopoulou, Ioannis Mitropoulos, Stephane Carlier, and Morteza Naghavi
Circulation 2005 112: e1-e2.
[Full Text]
-
Detection of Carotid Atherosclerotic Plaque Ulceration, Calcification, and Thrombosis by Multicontrast Weighted Magnetic Resonance Imaging
- Baocheng Chu, Marina S. Ferguson, Hunter Underhill, Norihide Takaya, Jianming Cai, Michel Kliot, Chun Yuan, and Thomas S. Hatsukami
Circulation 2005 112: e3-e4.
[Full Text]
-
Primary Lymphoma of the Heart
- Jeffrey Kuvin, Nisha Parikh, Robert Salomon, Arthur Tischler, Philip Daoust, Yevgeniy Arshanskiy, Karl Coyner, Philip Carpino, Natesa G. Pandian, Carey Kimmelstiel, Caroline Foote, John Erban, and Hassan Rastegar
Circulation 2005 112: e5-e6.
[Full Text]
-
Computed Tomography of the Coronary Arteries
- Frederick L. Ruberg
Circulation 2005 112: e7-e8.
[Full Text]
-
Letter Regarding Article by McNair et al, "SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia" Response
- W.A. Groenewegen, A.A.M. Wilde, William P. McNair, Lisa Ku, Matthew R.G. Taylor, Pam R. Fain, Eugene Wolfel, and Luisa Mestroni
Circulation 2005 112: e9-e10.
[Full Text]
-
Periodontal Disease and Coronary Heart Disease: A Reappraisal of the Exposure
- James D. Beck, Paul Eke, Gerardo Heiss, Phoebus Madianos, David Couper, Dongming Lin, Kevin Moss, John Elter, and Steven Offenbacher
Circulation 2005 112: 19-24.
[Abstract]
[Full Text]
-
Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure
- Salim Yusuf, Jan B. Ostergren, Hertzel C. Gerstein, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Bertil Olofsson, Jeffrey Probstfield, John V. McMurray on behalf of the Candesartan in Heart FailureAssessment of Reduction in Mortality and Morbidity Program (CHARM) Investigators
Circulation 2005 112: 48-53.
[Abstract]
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
R. L. Page II, K. J Utz, and E. E Wolfel
Should {beta}-Blockers Be Used in the Treatment of Cocaine-Associated Acute Coronary Syndrome?
Ann. Pharmacother.,
December 1, 2007;
41(12):
2008 - 2013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Venkateswaran and P. Shankar
The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a teaching hospital in Singapore
Postgrad. Med. J.,
May 1, 2007;
83(979):
329 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Cooper, J. D. Cooper, and J. M. Cooper
Cardiopulmonary Resuscitation: History, Current Practice, and Future Direction
Circulation,
December 19, 2006;
114(25):
2839 - 2849.
[Full Text]
[PDF]
|
 |
|